Skip to main content
. 2022 Apr 9;2022:8720438. doi: 10.1155/2022/8720438

Table 4.

Treg subset panel of the patients.

Parameters All (n = 40) Mild (n = 27) Severe (n = 13) P
CD4+CD25+ T cells, median ± IQR (%) 16.43 ± 11.43 17.54 ± 15.93 15.68 ± 8.84 0.3166#
CD4+CD25+ T cells, median ± IQR (/μL) 40.09 ± 56.26 40.48 ± 97.95 32.56 ± 34.53 0.0386#
Total Treg, mean ± SD (%) 18.73 ± 1.31 15.26 ± 0.97 25.94 ± 2.56 <0.0001
Total Treg, median ± IQR (/μL) 7.25 ± 11.82 7.21 ± 12.37 7.73 ± 8.27 0.4933#
Helios+ Treg, mean ± SD (%) 53.77 ± 4.51 65.09 ± 4.43 30.25 ± 6.86 <0.0001
Helios+ Treg, median ± IQR (/μL) 3.51 ± 9.38 4.74 ± 9.93 1.07 ± 3.16 0.0127#
Helios Treg, mean ± SD (%) 45.22 ± 4.53 33.57 ± 4.47 69.42 ± 6.58 <0.0001
Helios Treg, median ± IQR (/μL) 2.78 ± 4.48 2.18 ± 2.64 4.73 ± 4.54 0.0308#
CD39+ Treg, mean ± SD (%) 32.01 ± 3.26 26.74 ± 3.58 42.95 ± 5.81 0.0177
CD39+ T cell, median ± IQR (/μL) 1.68 ± 3.88 1.32 ± 3.20 1.79 ± 3.81 0.4133#
CD39 Treg, mean ± SD (%) 66.61 ± 3.17 71.38 ± 3.48 56.69 ± 5.81 0.0278
CD39 Treg, median ± IQR (/μL) 5.40 ± 7.56 6.43 ± 9.44 3.09 ± 5.12 0.1130#
CD45RA+ Treg, median ± IQR (%) 13.98 ± 15.33 11.63 ± 8.09 27.27 ± 16.14 0.0028#
CD45RA+ Treg, median ± IQR (/μL) 1.33 ± 1.42 1.17 ± 1.13 1.50 ± 1.70 0.2094#
CD45RA Treg, median ± IQR (%) 85.37 ± 15.35 88.37 ± 8.16 72.73 ± 15.81 0.0018#
CD45RA Treg, median ± IQR (/μL) 5.55 ± 10.63 5.55 ± 10.93 5.33 ± 5.42 0.2639#

#Tested by the Mann-Whitney U test; others were tested by the unpaired t-test; SD: standard deviation; IQR: interquartile range.